Crossref journal-article
Ovid Technologies (Wolters Kluwer Health)
Stroke (276)
Abstract

Background and Purpose —The present study was designed to investigate whether neuronally derived nitric oxide (NO) plays a toxic role in the cascade of cellular events triggered by global cerebral ischemia in rats. Methods —7-Nitroindazole (7-NI) was used as a selective inhibitor of neuronal NO synthase. Global ischemia was induced for 20 minutes in anesthetized rats following the four-vessel occlusion model. Electroencephalogram and brain and body temperatures were continuously monitored. All rats were thermoregulated for the entire duration of anesthesia. 7-NI (25 mg/kg) or its vehicle was given intraperitoneally just after the carotid clamping and again 1 hour later. Rats were randomly divided into four groups: (1) vehicle (n=7); (2) 7-NI (n=7); (3) l -arginine (300 mg/kg IP)+7-NI (n=7); and (4) 7-NI associated with warming to 37°C for 7 hours after disruption of anesthesia to compensate for the decrease in temperature induced by 7-NI (n=9). Seven days after ischemia, hippocampal CA1 damage was evaluated by classic histology. The lesion was scored with the use of a point scale, and the surviving neurons were counted. Results —Lesion scores were significantly lower and neuron counts higher in the two (warmed and unwarmed) groups of rats in which 7-NI was given alone than in vehicle- and l -arginine+7-NI–treated rats. Conclusions —The results indicate that 7-NI was neuroprotective in 20-minute global ischemia in rats and that the neuroprotective effect of 7-NI was mostly due to the blockade of NO synthesis, suggesting that NO released from neurons in ischemic conditions has a deleterious influence on hippocampal pyramidal neurons.

Authors 5
  1. Kazunori Nanri (first)
  2. Céline Montécot (additional)
  3. Véronique Springhetti (additional)
  4. Jacques Seylaz (additional)
  5. Elisabeth Pinard (additional)
References 58 Referenced 53
  1. 10.1038/jcbfm.1993.48
  2. 10.1161/str.24.11.7694393
  3. 10.1016/0006-8993(93)91053-U
  4. 10.1038/jcbfm.1994.92
  5. 10.1161/str.27.4.747
  6. 10.1016/S0166-2236(96)10074-6
  7. 10.1038/jcbfm.1994.25
  8. 10.1161/str.28.6.1283
  9. 10.1097/00001756-199206000-00020
  10. 10.1016/0306-4522(94)90054-X
  11. 10.1016/0014-2999(94)90360-3
  12. 10.1016/0304-3940(92)90062-C
  13. 10.1161/str.25.2.7508155
  14. 10.1126/science.7522345
  15. 10.1016/0306-4522(95)00563-3
  16. 10.1097/00004647-199607000-00010
  17. Benveniste H. The excitotoxin hypothesis in relation to cerebral ischemia. Cerebrovasc Brain Metab Rev. 1991;3:213–245. / Cerebrovasc Brain Metab Rev (1991)
  18. 10.1016/0304-3940(91)90147-L
  19. 10.1002/cne.903310107
  20. 10.1016/0166-2236(92)90021-Y
  21. 10.1073/pnas.91.6.2151
  22. 10.1016/0306-4522(94)90514-2
  23. 10.1073/pnas.88.14.6368
  24. 10.1523/JNEUROSCI.16-08-02479.1996
  25. 10.1152/ajpcell.1996.271.5.C1424
  26. 10.1016/0304-3940(96)12669-0
  27. 10.1016/0028-3908(94)90046-9
  28. Moore PK Bland-Ward PA. 7-Nitroindazole: an inhibitor of nitric oxide synthase. In: Abelson JN Simon MI eds. Methods in Enzymology. San Diego Calif: Academic Press; 1996;268:393–398. (10.1016/S0076-6879(96)68041-0)
  29. 10.1111/j.1476-5381.1993.tb13796.x
  30. 10.1523/JNEUROSCI.15-12-08419.1995
  31. 10.1038/jcbfm.1994.123
  32. 10.1016/0014-2999(96)00387-1
  33. 10.1016/0304-3940(89)90549-1
  34. 10.1111/j.1748-1716.1992.tb09462.x
  35. 10.1038/jcbfm.1993.71
  36. 10.1097/00004647-199605000-00014
  37. 10.1161/str.10.3.37614
  38. 10.1016/0306-4522(88)90276-X
  39. 10.1111/j.1476-5381.1993.tb13795.x
  40. 10.1097/00001756-199410000-00039
  41. 10.1016/S0306-4522(97)00566-6
  42. 10.1073/pnas.87.2.682
  43. 10.1038/jcbfm.1995.96
  44. Montécot C, Borredon J, Seylaz J, Pinard E. Nitric oxide of neuronal origin is involved in cerebral blood flow increase during seizures induced by kainate. J Cereb Blood Flow Metab. 1997;7:94–99. / J Cereb Blood Flow Metab (1997)
  45. 10.1073/pnas.91.10.4214
  46. 10.1161/str.28.11.2259
  47. 10.1016/S0021-9258(17)36726-1
  48. Di Monte DA, Royland JE, Jakowec MW, Langston JW. Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase. J Neurochem. 1996;67:2443–2450. (10.1046/j.1471-4159.1996.67062443.x) / J Neurochem (1996)
  49. Itzhak Y, Ali SF. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J Neurochem. 1996;67:1770–1773. (10.1046/j.1471-4159.1996.67041770.x) / J Neurochem (1996)
  50. 10.1097/00001756-199603220-00028
  51. 10.1038/jcbfm.1995.97
  52. 10.1016/0006-8993(95)01387-3
  53. Siesjö BK, Agardh CD, Bengtsson F. Free radicals and brain damage: a speculative synthesis. Cerebrovasc Brain Metab Rev. 1989;1:165–211. / Cerebrovasc Brain Metab Rev (1989)
  54. Lipton SA Stamler JS. Neuronal injury or protection by nitric oxide-related species. In: Bar PR Beal MF eds. Neuroprotection in CNS Diseases. New York NY: Marcel Dekker Inc; 1997:121–130.
  55. Beal MF. Therapeutic effects of nitric oxide synthase inhibition in neuronal injury. In: Bar PR Beal MF eds. Neuroprotection in CNS Diseases. New York NY: Marcel Dekker Inc; 1997:131–145. (10.1016/B978-012525445-8/50008-4)
  56. 10.1097/00004647-199711000-00007
  57. 10.1126/science.7522345
  58. Iadecola C, Zhang F, Xu X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am J Physiol. 1995;268:R286–R292. / Am J Physiol (1995)
Dates
Type When
Created 14 years, 2 months ago (June 17, 2011, 4:08 p.m.)
Deposited 1 year, 3 months ago (May 12, 2024, 6:23 p.m.)
Indexed 1 month, 1 week ago (July 24, 2025, 8:15 a.m.)
Issued 27 years, 3 months ago (June 1, 1998)
Published 27 years, 3 months ago (June 1, 1998)
Published Print 27 years, 3 months ago (June 1, 1998)
Funders 0

None

@article{Nanri_1998, title={The Selective Inhibitor of Neuronal Nitric Oxide Synthase, 7-Nitroindazole, Reduces the Delayed Neuronal Damage Due to Forebrain Ischemia in Rats}, volume={29}, ISSN={1524-4628}, url={http://dx.doi.org/10.1161/01.str.29.6.1248}, DOI={10.1161/01.str.29.6.1248}, number={6}, journal={Stroke}, publisher={Ovid Technologies (Wolters Kluwer Health)}, author={Nanri, Kazunori and Montécot, Céline and Springhetti, Véronique and Seylaz, Jacques and Pinard, Elisabeth}, year={1998}, month=jun, pages={1248–1254} }